News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Vivek Subbiah: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Vivek Subbiah/LinkedIn
Apr 20, 2025, 09:19

Vivek Subbiah: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an article by Richard A. Furie, et al. on X:

“Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis:

  • Obinutuzumab = a humanized type II anti-CD20 monoclonal antibody approved in CLL.

A nice example of drug repurposing.”

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Authors: Richard A. Furie, et al.

Vivek Subbiah: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Active Lupus Nephritis cancer CLL drug repurposing early-phase drug development fight against cancer Global fight against cancer Monoclonal Antibody Obinutuzumab OncoDaily Oncology Sarah Cannon Research Institute Vivek Subbiah
Special Coverage
Blog
Apr 20, 2025, 12:40
Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC - LUNGevity Foundation
Science
Apr 20, 2025, 12:33
Naveen Pemmaraju: Idarubicin and Cytarabine for patients with relapsed and/or refractory AML
Blog
Apr 20, 2025, 12:23
Proud to have over 70 Cardio-Oncology Centers of Excellence around the world - International Cardio-Oncology Society
Blog
Apr 20, 2025, 12:18
Every child deserves a safe, welcoming space during cancer treatment - Childhood Cancer International
Blog
Apr 20, 2025, 12:15
Hidehito HORINOUCHI: Honored to have been nominated for IASLC 2025 Board of Directors Election
Societies
Apr 20, 2025, 12:10
Where to Study to Become ASCO President: 2025 Institutional Rankings
Blog
Apr 20, 2025, 12:03
NCODA - HealthWell Foundation has opened a fund to support individuals living with NETs
Blog
Apr 20, 2025, 12:02
Himil Mahadevia: Humbled to receive the 2025 Conquer Cancer Merit Award for our study on CART outcomes
Blog
Apr 20, 2025, 11:57
David Zaas: Inspiring day with the team at Atrium Health Wake Forest Baptist Wilkes Medical Center
Blog
Apr 20, 2025, 11:55
ESMO Fellowship applications are now open!
Blog
Apr 20, 2025, 11:55
Petros Grivas: Support to our fundraising effort for bladder cancer
Blog
Apr 20, 2025, 11:51
C. Ola Landgren: The 11th Annual Miami Myeloma MRD Meeting was a huge success!